LUMAKRAS
Active substance: sotorasib
TABLET, COATED · SOTORASIB 240 mg/1
United StatesActive
Marketing holder: Amgen Inc
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- SOTORASIB · 240 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208e-7a30-727a-bb7f-a6b0ab8c6969,01a1209b-3c9e-79cc-acdb-c948c102bb08,01a1209d-8ce1-7cd4-a4aa-e642798368ae;count=3 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 55513-512
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 55513-512 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 55513-512 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 55513-512 · Verified 2026-10-09 · open in source